Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies

I Landa, N Pozdeyev, C Korch, LA Marlow… - Clinical Cancer …, 2019 - AACR
Purpose: Thyroid cancer cell lines are valuable models but have been neglected in
pancancer genomic studies. Moreover, their misidentification has been a significant …

Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy

C Jungels, JM Pita, G Costante - Current opinion in oncology, 2023 - journals.lww.com
The molecular profiling of tumour samples is elucidating the genetic alterations involved in
ATC development, and new preclinical models are under study to define innovative …

Mouse models of thyroid cancer: bridging pathogenesis and novel therapeutics

Y Jin, M Liu, R Sa, H Fu, L Cheng, L Chen - Cancer Letters, 2020 - Elsevier
Due to a global increase in the incidence of thyroid cancer, numerous novel mouse models
were established to reveal thyroid cancer pathogenesis and test promising therapeutic …

[HTML][HTML] Authentication of human cell lines by STR DNA profiling analysis

Y Reid, D Storts, T Riss, L Minor - 2013 - europepmc.org
The earliest mammalian cell lines, established by Earle et al. in 1943, were derived from the
subcutaneous tissue of a C3H mouse strain and many cell lines still used today were …

Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells

CL Liu, YC Hsu, JJ Lee, MJ Chen, CH Lin… - Molecular and cellular …, 2020 - Elsevier
The pentose phosphate pathway (PPP) plays an important role in the biosynthesis of
ribonucleotide precursor and NADPH. Cancer cells frequently increase the flux of glucose …

Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer

GR Gimblet, J Whitt, HA Houson, D Lin, R Guenter… - Surgery, 2024 - Elsevier
Background Of the half a million cases of thyroid cancer diagnosed annually, 95% are
differentiated thyroid cancers. Although clinical guidelines recommend surgical resection …

[HTML][HTML] Targeting autophagy in thyroid cancers

W Wei, H Hardin, QY Luo - Endocrine-related cancer, 2019 - erc.bioscientifica.com
Thyroid cancer is one of the most common endocrine malignancies. Although the prognosis
for the majority of thyroid cancers is relatively good, patients with metastatic, radioiodine …

Novel anaplastic thyroid cancer PDXs and cell lines: expanding preclinical models of genetic diversity

A Maniakas, YC Henderson, H Hei… - The Journal of …, 2021 - academic.oup.com
Context Anaplastic thyroid cancer (ATC) is a rare, aggressive, and deadly disease. Robust
preclinical thyroid cancer models are needed to adequately develop and study novel …

Patient-derived tumor xenograft study with CDK4/6 inhibitor plus AKT inhibitor for the management of metastatic castration-resistant prostate cancer

AM Kase, J Gleba, JL Miller, E Miller, J Petit… - Molecular Cancer …, 2024 - AACR
Metastatic castration-resistant prostate cancer (mCRPC) is an aggressive malignancy with
poor outcomes. To investigate novel therapeutic strategies, we characterized three new …

Establishment and characterization of four novel thyroid cancer cell lines and PDX models expressing the RET/PTC1 rearrangement, BRAFV600E, or RASQ61R as …

RE Schweppe, N Pozdeyev, LA Pike, C Korch… - Molecular Cancer …, 2019 - AACR
Cancer cell lines are critical models to study tumor progression and response to therapy. In
2008, we showed that approximately 50% of thyroid cancer cell lines were redundant or not …